With the support of Zymo Research products, two California-based companies, Fulgent Genetics located in Temple City and Curative Inc. based in Menlo Park, have received Emergency Use Authorizations from the US Food and Drug Administration for their rRT-PCR tests for the detection of SARS-CoV-2 in specimens collected from individuals.
Having pivoted from a COVID testing company, Curative is an employer-based health insurance offering that aims to improve health outcomes through cost transparency & easy use.